In September 2013, the Sheik Zayed Institute for Pediatric Surgical Innovation (SZI) at the Children’s National Health System and the University of Maryland A. James Clark School of Engineering received a U.S. Food and Drug Administration (FDA) P50 grant to form the National Capital Consortium for Pediatric Device Innovation (NCC-PDI).
Awarded by the FDA’s Office of Orphan Products Development, the 2013 grant was designated to bring together teams with excellence and expertise in delivering business, regulatory, legal, scientific, engineering, and clinical services for children.
The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) serves as a critical device development resource by providing expert
NCC-PDI’s diverse team of collaborators is composed of lead members, members, and affiliated members, according to their level of involvement
The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) serves as a critical device development resource by providing expert advice
NCC-PDI is structured to provide critical mass for clinical, regulatory, business, scientific, and engineering expertise. Several faculty researchers hold affiliations with both SZI and the Clark School, adding to the Consortium’s wealth of experience in pediatric device development.